BDBM708493 3-(5-((3-(4-(2-((3r, 5r,7r)-adamantan-1- yl)ethyl)piperazin- 1-yl)propyl)thio)-2- methyl-4-oxoquinazolin-3(4H)- yl)piperidine-2,6-dione::US20240425475, Compound GT-03306

SMILES Cc1nc2cccc(SCCCN3CCN(CCC45CC6CC(CC(C6)C4)C5)CC3)c2c(=O)n1C1CCC(=O)NC1=O

InChI Key InChIKey=AFGXZDCBACJZIF-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 708493   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM708493(3-(5-((3-(4-(2-((3r, 5r,7r)-adamantan-1- yl)ethyl)...)
Affinity DataIC50: 1.57E+3nMAssay Description:1. According to the instructions of the CEREBLON BINDING kits, the compounds to be tested of the present invention and lenalidomide were serially dil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent